PhRMA and BIO ramp up ad spend for presidential election year; Super Bowl Sunday features three pharma ads; Pfizer solidifies leadership team
Celebrity success or fail? Here's what the American Lung Association, Pfizer and Tim Daly likely did not see coming when they joined forces to raise awareness about pneumococcal pneumonia.
Heaven knows the industry is itself to blame for some of the dopier recurring imagery in its DTC spots, like models clad in white linen riding horses on deserted stretches of beach.
Johnson & Johnson collaborates with biotech on diabetes stem-cell treatment; the FDA warms up to Remicade biosimilar; Woodcock warns about biosimilar backlog
The Ketchum veteran joined the nonprofit healthcare system in mid-2014.
A House lawmaker called pricing strategies used by Turing and Valeant "repulsive."
Burcin's charge is to keep momentum going at the indie agency, known for placing ice-cream carts outside of rival agencies and other recruiting tactics.
Valeant to push for changes to financial-assistance rules; House to hold hearing on drug-pricing practices; FDA committee says Lundbeck can add information to leaflet
After Bill McEllen's departure, the company promoted Mark Willmann to lead the agency.
FitzPatrick is departing the company as it evaluates its 150 agency partnerships.